Two-component signal transduction as a target for microbial anti-infective therapy.
Barrett
J F
JF
Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492, USA.
Hoch
J A
JA
D000900:Anti-Bacterial Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000378:metabolism / Q000472:pathogenicity; D004352:Drug Resistance, Microbial / Q000502:physiology; D004783:Environmental Microbiology; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology; D014774:Virulence
D000900:Anti-Bacterial Agents